WhiteSands Alcohol & Drug Rehab Lakeland has published a new in-depth educational resource on its website examining the medical and behavioral risks associated with mixing Eliquis, a commonly ...
In 2022, the Inflation Reduction Act authorized and required Health and Human Services for the first time to negotiate the maximum price drug manufacturers can charge Medicare plans for 10 popular ...
Negotiated lower Medicare costs for 10 popular prescription drugs went into effect Thursday. How much those savings will be passed on to Medicare Part D and applicable Advantage plan enrollees is ...
Pharmaceutical Technology on MSN
Trump administration ties pricing deals with another nine pharma companies
With the latest batch’s agreements, only three out of the 17 drugmakers initially targeted by Trump have not signed pricing ...
Pharmaceutical Technology on MSN
AstraZeneca pulls Andexxa from US market after post-marketing fatalities
AstraZeneca has pulled its anticoagulant therapy, Andexxa (recombinant coagulation factor Xa), from the US market after ...
People taking blood thinners, otherwise known as anticoagulants, could be at risk of disrupting their treatment with a common ...
Bristol Myers (BMY) stock is in focus as the firm to offer its Pfizer (PFE)-partnered Eliquis, free to Medicaid as part of a ...
According to a new study, among patients receiving extended anticoagulation with apixaban for cancer-associated VTE, four ...
President Donald Trump announced deals with nine pharmaceutical companies on Friday, the latest in a series of pacts designed to lower drug prices for some Americans in exchange for a three-year ...
Pfizer shares fall after a muted 2026 outlook, with projected modest revenue growth, lower COVID sales and deal dilution weighing on investor sentiment.
Bristol Myers Squibb (NYSE: BMY, “BMS”) today announced an agreement with the U.S. government to provide Eliquis® (apixaban), an oral anticoagulant relied upon by millions of Americans daily, for free ...
NEW YORK – As testing for the APOE ε4 variant is becoming more commonplace among Alzheimer's disease patients, new research linking the biomarker to a higher risk of intracranial hemorrhage in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results